a developer of antibody-based therapeutic drugs
Industry Biotechnology
A.I.dvisor indicates that over the last year, AFMD has been loosely correlated with NTLA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AFMD jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To AFMD | 1D Price Change % | ||
---|---|---|---|---|
AFMD | 100% | -2.67% | ||
NTLA - AFMD | 36% Loosely correlated | -6.15% | ||
ARWR - AFMD | 34% Loosely correlated | -1.02% | ||
XERS - AFMD | 32% Poorly correlated | -3.17% | ||
GPCR - AFMD | 32% Poorly correlated | +3.63% | ||
CRSP - AFMD | 29% Poorly correlated | -5.90% | ||
More |
Ticker / NAME | Correlation To AFMD | 1D Price Change % |
---|---|---|
AFMD | 100% | -2.67% |
drugs theme (254 stocks) | 28% Poorly correlated | -1.67% |
therapeutics theme (53 stocks) | 21% Poorly correlated | -2.40% |
biotechnology theme (238 stocks) | 10% Poorly correlated | -1.76% |
antibody theme (6 stocks) | 9% Poorly correlated | -4.63% |
europe theme (179 stocks) | 9% Poorly correlated | -0.09% |